Table 3.
Reproductive outcomes by the study group (ET-MII, ET-MIX, ET-IVMC)
| ET-MII (n = 3581) | ET-MIX (n = 264) | ET-IVMC (n = 90) | p-value1 | |
|---|---|---|---|---|
| Biochemical pregnancy, n (%) | 1319/3577 (36.9) | 84/264 (31.8) | 10/90 (11.1)* | < 0.001 |
| Implantation rate at 7 weeks, sacs/transferred embryos (%) | 1174/7061 (16.6) | 68/628 (10.8) | 9/118 (7.6)* | < 0.001 |
| Clinical pregnancy, n (%) | 1061/3520 (30.1) | 65/264 (24.6) | 9/90 (10.0)* | < 0.001 |
| Ongoing pregnancy, n (%) | 858/3519 (24.4) | 49/263 (18.7) | 7/90 (7.8)* | < 0.001 |
| Live birth, n (%) | 632/3348 (18.9) | 39/255 (15.3) | 5/89 (5.6)* | 0.003 |
ET embryo transfer, IVMC in vitro meiotic completion, n number of cycles, MII metaphase II
*Statistically siginificant difference after pairwise comparison with Bonferroni’s correction between this group and ICSI-MII
1Pearson’s Chi2 test